CTS implements Ortho VIP Viral Marker Testing Platform

25Jan

CTS implements Ortho VIP Viral Marker Testing Platform

25 Jan, 2021 | Return|

On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the Prism to the VIP is one of the most significant changes we have made in the past three years. We implemented the new system through the dedication and extraordinary effort of everyone across the enterprise. Congratulations on this important success!

FDA Releases Zika Virus (ZIKV) Guidance and Grifols ZIKV Assay Licensed

O'Dina Hurlburt | 0 Comments

On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...

Long-time CTS Leader Josh Moon to Guide Operations as Chief Operating Officer

SuperUser Account | 0 Comments

Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...

CTS Tampa Implementation date change for Ultrio Elite

Lindsey Houghton | 0 Comments

CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...

Upcoming HCV Testing Algorithm Change

Lindsey Houghton | 0 Comments

FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...

Update on CTS Implementation of the Grifols Procleix Ultrio Elite Assay

Lindsey Houghton | 0 Comments

In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...

Renewed licenses now available on the website

Lindsey Houghton | 0 Comments

As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....

Articles